HK1232207A1 - 多不飽和脂肪酸的衍生物作為藥物的用途 - Google Patents

多不飽和脂肪酸的衍生物作為藥物的用途

Info

Publication number: HK1232207A1
Authority: HK; Hong Kong
Prior art keywords: derivates; medicaments; fatty acids; polyunsaturated fatty; polyunsaturated
Prior art date: 2009-03-16

Application number

HK17105487.0A

Other languages

English (en)

Inventor

帕布羅．維森特．埃斯克里巴瑞茲

艾考貝斯特夏維爾．布斯科韋斯特

吉梅奈茲西爾維爾．特萊斯

科博林恩格溫多林．巴塞羅

卡耐拉斯維克多利亞．拉多

埃泰克森尼克埃瑪伊亞．馬希拉

瑪利亞．勞拉．馬丁

烏爾巴諾莫妮卡．海格拉

馬蒂奈茲拉斐爾．阿爾維萊斯

丹尼爾．霍拉茨奧．洛佩茨

Original Assignee

Lipopharma Therapeutics S L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-16

Filing date

2017-06-02

Publication date

2018-01-05

2017-06-02 Application filed by Lipopharma Therapeutics S L filed Critical Lipopharma Therapeutics S L

2018-01-05 Publication of HK1232207A1 publication Critical patent/HK1232207A1/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HK17105487.0A 2009-03-16 2017-06-02 多不飽和脂肪酸的衍生物作為藥物的用途 HK1232207A1 (zh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES200900725A ES2345241B1 (es)	2009-03-16	2009-03-16	Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.

Publications (1)

Publication Number	Publication Date
HK1232207A1 true HK1232207A1 (zh)	2018-01-05

Family

ID=42673244

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK17105487.0A HK1232207A1 (zh)	2009-03-16	2017-06-02	多不飽和脂肪酸的衍生物作為藥物的用途

Country Status (19)

Country	Link
US (7)	US9161928B2 (zh)
EP (2)	EP2409963B1 (zh)
JP (1)	JP5904592B2 (zh)
KR (4)	KR101833772B1 (zh)
CN (4)	CN109999018A (zh)
AU (6)	AU2010224749B2 (zh)
BR (1)	BRPI1009860A8 (zh)
CA (1)	CA2754963C (zh)
CL (1)	CL2011002268A1 (zh)
DK (2)	DK3159329T3 (zh)
ES (3)	ES2345241B1 (zh)
HK (1)	HK1232207A1 (zh)
HU (2)	HUE032027T2 (zh)
MX (1)	MX2011009614A (zh)
PL (1)	PL2409963T3 (zh)
PT (2)	PT3159329T (zh)
RU (1)	RU2513995C2 (zh)
SI (1)	SI3159329T1 (zh)
WO (1)	WO2010106211A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2345241B1 (es) *	2009-03-16	2011-09-08	Lipopharma Therapeutics	Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
CA3083907A1 (en)	2009-10-30	2011-05-05	Retrotope, Inc.	Alleviating oxidative stress disorders with pufa derivatives
WO2012148929A2 (en)	2011-04-26	2012-11-01	Retrotope, Inc.	Disorders implicating pufa oxidation
KR102112087B1 (ko)	2011-04-26	2020-05-18	레트로토프 인코포레이티드	에너지 프로세싱 손상 장애 및 미토콘드리아 결함
AU2012249917B2 (en)	2011-04-26	2017-06-15	Biojiva Llc	Neurodegenerative disorders and muscle diseases implicating PUFAs
AU2012249921B2 (en)	2011-04-26	2017-06-08	Biojiva Llc	Oxidative retinal diseases
ES2401629B1 (es) *	2011-10-07	2014-03-04	Universitat De Les Illes Balears	Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos.
KR101970151B1 (ko) *	2014-10-21	2019-04-19	유니버시다드 데 레스 일레스 발레아르스	하이드록시-트리글리세라이드의 합성 방법 및 질병의 예방 및 치료에 사용되는 하이드록시-트리글리세라이드의 용도
US20180024150A1 (en) *	2015-03-06	2018-01-25	Niigata University	Biomarker of dementia with lewy bodies
CN108698987B (zh)	2015-11-23	2021-07-13	乐巢拓普有限公司	1,4-二烯体系的位点特异性同位素标记
GB201521085D0 (en) *	2015-11-30	2016-01-13	Biozep As	Use
MX2019013683A (es) *	2017-05-16	2020-01-15	Ability Pharmaceuticals Sl	Una combinacion farmaceutica para el tratamiento de un cancer.
US10596165B2 (en)	2018-02-12	2020-03-24	resTORbio, Inc.	Combination therapies
IL314362A (en)	2018-06-15	2024-09-01	Janssen Pharmaceutica Nv	Rapamycin analogs and their uses
CA3163680A1 (en)	2019-12-05	2021-06-10	David John O'neill	Rapamycin analogs and uses thereof
AU2021212330A1 (en) *	2020-01-29	2022-09-22	Universitat De Les Illes Balears	Alpha-hydroxylated fatty-acid metabolites, medical uses of same and use as biomarkers
ES2846824B2 (es) *	2020-01-29	2022-01-19	Univ Illes Balears	Profarmacos de acidos grasos poliinsaturados y usos medicos de los mismos
CA3163864A1 (en)	2020-02-10	2021-08-19	Ability Pharmaceuticals S.L.	A pharmaceutical combination for the treatment of a cancer
CA3172351A1 (en)	2020-02-21	2021-08-26	Retrotope, Inc.	Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
US12109194B2 (en)	2021-02-05	2024-10-08	Biojiva Llc	Synergistic combination therapy for treating ALS

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8717816D0 (en)	1987-07-28	1987-09-03	Manchester Inst Science Tech	Fabric testing apparatus
GB2218984B (en) *	1988-05-27	1992-09-23	Renafield Limited	Process for preparing high-concentration mixtures of polyunsaturated fatty acids & their esters and their prophylactic or therapeutic uses
JPH05974A (ja) *	1991-06-21	1993-01-08	Sagami Chem Res Center	ハロゲン化不飽和アルキル化合物及びその前駆体
ES2161146B1 (es) *	1999-06-29	2002-07-01	Consejo Superior Investigacion	Compuestos antimicrobianos, uso y metodo para inducir resistencia a infecciones de bacterias en plantas.
US6344574B1 (en) *	2000-07-20	2002-02-05	The United States Of America As Represented By The Secretary Of Agriculture	Solvent fractionation of chicken fat for making lipid compositions enriched in unsaturated fatty acid-containing triacylglycerols
DE10106660A1 (de) *	2001-02-12	2002-08-29	Celanese Ventures Gmbh	Verfahren zur Herstellung von gamma-Linolensäure aus einer Ciliaten-Kultur durch Zusatz geeigneter Vorläufermoleküle zu dem Kulturmedium
ES2186576B1 (es) *	2001-10-11	2004-09-16	Universitat De Les Illes Balears	Acido 2-hidroxioleico para utilizar como medicamento.
SI2022775T1 (sl) *	2002-04-01	2015-03-31	University Of Southern California	Trihidroksi polinenasiäśeni eikosanoidi
US7135575B2 (en) *	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
EA010802B1 (ru) *	2004-11-19	2008-12-30	Мартек Байосайенсиз Корпорейшн	Оксилипины из полиненасыщенных жирных кислот с длинной цепью и способы их получения и применения
GB0428384D0 (en)	2004-12-24	2005-02-02	Sla Pharma Ag	Eicosapentaenoic acid
US8324276B2 (en) *	2005-01-24	2012-12-04	Pronova Biopharma Norge As	Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
EP1888727B1 (en) *	2005-05-04	2015-04-15	Pronova BioPharma Norge AS	New dha derivatives and their use as medicaments
CN101213281B (zh) *	2005-05-04	2013-03-13	普罗诺瓦生物医药挪威公司	新的dha衍生物及其作为药物的用途
US8059805B2 (en) *	2005-06-30	2011-11-15	Emc Corporation	Enhanced services provided using communication redirection and processing
JP2009502745A (ja)	2005-07-08	2009-01-29	マーテックバイオサイエンシーズコーポレーション	認知症および前認知症に関連した状態を治療するための多価不飽和脂肪酸
EP1772146A1 (en) *	2005-10-03	2007-04-11	Neuropharma, S.A.	Polyunsaturated fatty acids as bace inhibitors
WO2007058523A1 (en)	2005-11-17	2007-05-24	N.V. Nutricia	Composition with docosapentaenoic acid
ATE509624T1 (de) *	2005-12-23	2011-06-15	Nutricia Nv	Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
RU2009120568A (ru)	2006-11-01	2010-12-10	Пронова Биофарма Норге Ас (No)	Композиция
CA2667211A1 (en) *	2006-11-01	2008-05-08	Pronova Biopharma Norge As	Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar)
WO2008053340A1 (en) *	2006-11-03	2008-05-08	Pronova Biopharma Norge As	A combination product comprising at least one lipid substituted in the alpha position and at least one hypoglycemic agent
US20080234377A1 (en) *	2007-03-23	2008-09-25	Martek Biosciences Corporation	Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
ES2345241B1 (es)	2009-03-16	2011-09-08	Lipopharma Therapeutics	Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
ES2401629B1 (es) *	2011-10-07	2014-03-04	Universitat De Les Illes Balears	Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos.

2009
- 2009-03-16 ES ES200900725A patent/ES2345241B1/es active Active
2010
- 2010-03-15 MX MX2011009614A patent/MX2011009614A/es active IP Right Grant
- 2010-03-15 HU HUE10753158A patent/HUE032027T2/en unknown
- 2010-03-15 CN CN201910095352.2A patent/CN109999018A/zh active Pending
- 2010-03-15 PT PT162011324T patent/PT3159329T/pt unknown
- 2010-03-15 CA CA2754963A patent/CA2754963C/en active Active
- 2010-03-15 EP EP10753158.4A patent/EP2409963B1/en active Active
- 2010-03-15 EP EP16201132.4A patent/EP3159329B1/en active Active
- 2010-03-15 AU AU2010224749A patent/AU2010224749B2/en not_active Revoked
- 2010-03-15 PT PT107531584T patent/PT2409963T/pt unknown
- 2010-03-15 JP JP2012500281A patent/JP5904592B2/ja active Active
- 2010-03-15 CN CN2010800119398A patent/CN102356057A/zh active Pending
- 2010-03-15 DK DK16201132.4T patent/DK3159329T3/da active
- 2010-03-15 US US13/257,128 patent/US9161928B2/en active Active
- 2010-03-15 ES ES10753158.4T patent/ES2613606T3/es active Active
- 2010-03-15 KR KR1020117024210A patent/KR101833772B1/ko active Active
- 2010-03-15 RU RU2011141850/04A patent/RU2513995C2/ru active
- 2010-03-15 KR KR1020207005917A patent/KR102233102B1/ko active Active
- 2010-03-15 CN CN201610773061.0A patent/CN106349058B/zh active Active
- 2010-03-15 KR KR1020187005245A patent/KR20180021931A/ko not_active Ceased
- 2010-03-15 SI SI201032041T patent/SI3159329T1/sl unknown
- 2010-03-15 PL PL10753158T patent/PL2409963T3/pl unknown
- 2010-03-15 CN CN201610773030.5A patent/CN106420686B/zh active Active
- 2010-03-15 BR BRPI1009860A patent/BRPI1009860A8/pt not_active Application Discontinuation
- 2010-03-15 DK DK10753158.4T patent/DK2409963T3/en active
- 2010-03-15 ES ES16201132T patent/ES2820025T3/es active Active
- 2010-03-15 HU HUE16201132A patent/HUE051850T2/hu unknown
- 2010-03-15 KR KR1020197004239A patent/KR20190018754A/ko not_active Ceased
- 2010-03-15 WO PCT/ES2010/070153 patent/WO2010106211A1/es active Application Filing
2011
- 2011-09-13 CL CL2011002268A patent/CL2011002268A1/es unknown
2015
- 2015-09-29 US US14/869,080 patent/US9763907B2/en active Active
- 2015-09-29 US US14/869,045 patent/US9763906B2/en active Active
2016
- 2016-07-13 US US15/209,540 patent/US9907772B2/en active Active
- 2016-10-07 AU AU2016238970A patent/AU2016238970B2/en not_active Revoked
2017
- 2017-06-02 HK HK17105487.0A patent/HK1232207A1/zh unknown
- 2017-08-22 US US15/683,379 patent/US10201515B2/en active Active
2018
- 2018-06-05 AU AU2018203976A patent/AU2018203976B2/en not_active Expired - Fee Related
- 2018-12-18 US US16/224,262 patent/US20190365690A1/en not_active Abandoned
2019
- 2019-09-06 AU AU2019226257A patent/AU2019226257B2/en active Active
2020
- 2020-04-22 US US16/855,463 patent/US11253497B2/en active Active
- 2020-07-13 AU AU2020205214A patent/AU2020205214B2/en active Active
- 2020-07-13 AU AU2020205213A patent/AU2020205213B2/en active Active

Also Published As

Publication number	Publication date
CN109999018A (zh)	2019-07-12
CN102356057A (zh)	2012-02-15
HUE032027T2 (en)	2017-08-28
ES2345241B1 (es)	2011-09-08
US10201515B2 (en)	2019-02-12
CA2754963C (en)	2022-02-08
JP5904592B2 (ja)	2016-04-13
EP3159329A1 (en)	2017-04-26
AU2018203976A1 (en)	2018-06-21
RU2011141850A (ru)	2013-04-27
DK3159329T3 (da)	2020-11-09
US11253497B2 (en)	2022-02-22
SI3159329T1 (sl)	2021-01-29
US20200352891A1 (en)	2020-11-12
HUE051850T2 (hu)	2021-03-29
BRPI1009860A2 (pt)	2016-03-08
AU2019226257B2 (en)	2020-05-07
CA2754963A1 (en)	2010-09-23
US20160158181A1 (en)	2016-06-09
AU2016238970B2 (en)	2018-03-08
AU2020205214A1 (en)	2020-07-30
CN106420686B (zh)	2020-05-22
AU2020205213A1 (en)	2020-07-30
AU2020205213B2 (en)	2021-02-25
US20170035720A1 (en)	2017-02-09
ES2613606T3 (es)	2017-05-24
EP2409963A4 (en)	2013-10-02
KR102233102B1 (ko)	2021-03-26
ES2345241A1 (es)	2010-09-17
CN106349058B (zh)	2020-01-14
CN106420686A (zh)	2017-02-22
AU2016238970A1 (en)	2016-11-03
US9763906B2 (en)	2017-09-19
AU2018203976B2 (en)	2019-06-06
AU2019226257A1 (en)	2019-09-26
AU2010224749B2 (en)	2016-07-07
US9763907B2 (en)	2017-09-19
US20160158180A1 (en)	2016-06-09
US9161928B2 (en)	2015-10-20
WO2010106211A1 (es)	2010-09-23
RU2513995C2 (ru)	2014-04-27
BRPI1009860A8 (pt)	2019-12-17
KR20200024953A (ko)	2020-03-09
DK2409963T3 (en)	2017-02-27
KR101833772B1 (ko)	2018-03-02
KR20180021931A (ko)	2018-03-05
AU2010224749A1 (en)	2011-10-13
AU2020205214B2 (en)	2021-02-18
EP3159329B1 (en)	2020-08-12
EP2409963A1 (en)	2012-01-25
KR20110137365A (ko)	2011-12-22
US20180085332A1 (en)	2018-03-29
MX2011009614A (es)	2012-01-20
KR20190018754A (ko)	2019-02-25
CL2011002268A1 (es)	2012-01-27
EP2409963B1 (en)	2017-01-04
JP2012520344A (ja)	2012-09-06
US9907772B2 (en)	2018-03-06
ES2820025T3 (es)	2021-04-19
CN106349058A (zh)	2017-01-25
US20190365690A1 (en)	2019-12-05
US20120108550A1 (en)	2012-05-03
PT2409963T (pt)	2017-02-15
PT3159329T (pt)	2020-11-13
PL2409963T3 (pl)	2017-05-31

Publication	Publication Date	Title
HK1232207A1 (zh)	2018-01-05	多不飽和脂肪酸的衍生物作為藥物的用途
EP2498602A4 (en)	2014-05-21	STABILIZED FORMULATIONS FROM FATTY ACIDS
SG10201605082RA (en)	2016-08-30	Production Of Omega-Amino Fatty Acids
EP2483233A4 (en)	2013-08-14	HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS
EP2425007A4 (en)	2013-01-02	PREPARATION OF FATTY ACID ESTERS
PH12012500561A1 (en)	2012-10-22	Production of fatty acid derivatives
EP2417246A4 (en)	2015-11-04	PRODUCTION OF FATTY ACID DERIVATIVES
EP2521447A4 (en)	2014-04-30	FATTY FATTY ACID DERIVATIVES AND USES THEREOF
HK1205645A1 (zh)	2015-12-24	包含 -α生育酚和多不飽和脂肪酸的營養組合物
ZA201403784B (en)	2015-09-30	Compositions comprising 20-carbon fatty acids and methods of making and using same
PL2349250T3 (pl)	2017-09-29	Kwasy Tłuszczowe Do Stosowania Jako Lek
IL213354A (en)	2017-06-29	Alpha-monoclonal fatty acid alpha history for use as a drug
IL214887A0 (en)	2011-11-30	Fatty acid monoglyceride compositions
GB201304550D0 (en)	2013-04-24	Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof
EP2726086A4 (en)	2015-04-29	COMPOSITIONS CONTAINING FATTY NITROACIDS
IL219958A0 (en)	2012-07-31	Omega-3 fatty acid enriched meat compositions
HK1185806A1 (zh)	2014-02-28	含有多不飽和脂肪酸的組合物
GB0904300D0 (en)	2009-04-22	Essential fatty acid compounds
AU2010903057A0 (en)	2010-07-22	Acetylenation of fatty acids
GB201021862D0 (en)	2011-02-02	Improvements in the manufacture of fatty acids
GB201104653D0 (en)	2011-05-04	Improvements in the manufacture of fatty acids
GB201021369D0 (en)	2011-01-26	Radioiodinated fatty acids